Pyran, Inc. (Madison, Wisc.) announced that it is expanding sales of 1,5-pentanediol (PDO) to select, pre-approved customers as it has achieved critical milestones necessary to begin operating its world-scale commercial plant for the product in 2026. After securing an additional $1.5 million in new funding, Pyran has scaled its technology and produced ton quantities of its bio-based product.
Source: Pyran
The company announced it is now selling its product to early customers to allow them to qualify the bio-based product in their applications. Potential customers interested in obtaining a sample should contact the company.
“Our successful manufacturing campaign with renewable feedstocks now enables customers to further expand their businesses with a better performing and more sustainable product,” said Kevin Barnett, Pyran co-founder and chief technology officer. “We have ramped up our capabilities so that our customers can do the same.”
The company recently produced ton quantities of 1,5 PDO and validated the technology at commercial scale in a toll manufacturing facility. The toll manufacturing production run also enabled the company to gather information required for the engineering necessary for the company’s world-scale commercial plant.
Pyran uses renewable feedstocks, such as corn cobs, wood and sugarcane bagasse, to make 1,5 PDO, which enhances the performance of everyday products, such as paints, coatings, adhesives and more. The company’s renewable 5-carbon products replace expensive and supply-constrained petroleum-based chemicals.
Pyran closed on the second half of its Series A equity funding round earlier this year, raising $1.5 million. Coupled with its initial Series A equity funding, Pyran has raised nearly $4 million between the two tranches and approximately $7.5 million in grants, loans and equity capital since its founding in 2018.